PALISADE BIO, INC. — Director's Dealing 2023

Nov 24, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PALISADE BIO, INC. (PALI)
CIK: 0001357459
Period of Report: 2023-11-21

Reporting Person: GRAY MARY ANN (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-11-21	Restricted Stock Units	$	A	5820	Acquired		Common Stock (5820)	Direct
2023-11-21	Common Stock Options	$0.59	A	6880	Acquired	2033-11-21	Common Stock (6880)	Direct

Footnotes

F1: Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee.

F2: The grants vest fully on the one (1) year anniversary of the grant date.

F3: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

F4: N/A.

F5: Each option represents the right to purchase one share of common stock at the exercise price.